BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+9.76%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$634M
AUM Growth
+$634M
(+4.5%)
Cap. Flow
-$31.8M
Cap. Flow
% of AUM
-5.02%
Top 10 Holdings %
Top 10 Hldgs %
52.68%
Holding
60
New
15
Increased
10
Reduced
19
Closed
10
Top Buys
| 1 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$27.1M |
| 2 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$18.7M |
| 3 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$12.1M |
| 4 |
KALA BIO
KALA
|
$10.8M |
| 5 |
NUVA
NuVasive, Inc.
NUVA
|
$9.2M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$30.8M |
| 2 |
RXDX
Ignyta, Inc.
RXDX
|
$30.7M |
| 3 |
Iovance Biotherapeutics
IOVA
|
$24.1M |
| 4 |
ENDP
Endo International plc
ENDP
|
$18.9M |
| 5 |
AngioDynamics
ANGO
|
$14.2M |
Sector Composition
| 1 | Healthcare | 88.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LJPC
1
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $49.3M | 7.69% | 1,656,720 +626,854 | +61% | +$18.7M |
|
|
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $44.3M | 6.91% | 1,443,948 -1,003,798 | -41% | -$30.8M |
|
3
Heron Therapeutics
HRTX
$207M
| $43.6M | 6.8% | 1,581,416 -447,102 | -22% | -$12.3M |
|
|
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $36.4M | 5.67% | 2,564,175 -453,846 | -15% | -$6.44M |
|
|
CORI
5
DELISTED
Corium International, Inc.
CORI
| $35.8M | 5.58% | 3,119,645 -312,681 | -9% | -$3.59M |
|
|
ADMS
6
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $27.1M | 4.23% | +1,135,203 | New | +$27.1M |
|
7
Travere Therapeutics
TVTX
$1.56B
| $26.3M | 4.11% | 1,178,226 -463,642 | -28% | -$10.4M |
|
|
SBBP
8
DELISTED
Strongbridge Biopharma plc.
SBBP
| $24.7M | 3.85% | 2,793,752 -392,943 | -12% | -$3.48M |
|
|
SCTL
9
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $24.6M | 3.84% | 2,236,025 -200,000 | -8% | -$2.2M |
|
|
ZGNX
10
DELISTED
Zogenix, Inc.
ZGNX
| $21.5M | 3.35% | 537,380 +80,300 | +18% | +$3.22M |
|
|
GWPH
11
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $19.7M | 3.07% | 175,030 +52,100 | +42% | +$5.87M |
|
|
AVDL
12
Avadel Pharmaceuticals
AVDL
$1.43B
| $19.1M | 2.98% | 2,624,663 +32,942 | +1% | +$240K |
|
|
PETX
13
DELISTED
Aratana Therapeutics, Inc.
PETX
| $18.9M | 2.95% | 4,294,426 | – | – |
|
14
Integra LifeSciences
IART
$1.18B
| $16.5M | 2.57% | 298,424 -32,176 | -10% | -$1.78M |
|
15
Catalyst Pharmaceutical
CPRX
$2.52B
| $16.3M | 2.54% | 6,812,764 -284,536 | -4% | -$680K |
|
|
16
AngioDynamics
ANGO
$417M
| $15.7M | 2.45% | 911,707 -820,654 | -47% | -$14.2M |
|
|
17
Iovance Biotherapeutics
IOVA
$807M
| $15.4M | 2.4% | 912,987 -1,427,624 | -61% | -$24.1M |
|
|
NUVA
18
DELISTED
NuVasive, Inc.
NUVA
| $13.5M | 2.1% | 258,292 +176,192 | +215% | +$9.2M |
|
|
AMAG
19
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $12.1M | 1.88% | +598,800 | New | +$12.1M |
|
|
20
KALA BIO
KALA
$78.8M
| $10.8M | 1.68% | +681,239 | New | +$10.8M |
|
|
ATRS
21
DELISTED
Antares Pharma, Inc.
ATRS
| $10.3M | 1.6% | 4,673,247 +137,600 | +3% | +$303K |
|
|
BDSI
22
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $9.63M | 1.5% | 4,278,819 -355,300 | -8% | -$799K |
|
23
Glaukos
GKOS
$5.5B
| $9.06M | 1.41% | +293,900 | New | +$9.06M |
|
24
AnaptysBio
ANAB
$569M
| $8.24M | 1.28% | +79,200 | New | +$8.24M |
|
25
Cigna
CI
$80.3B
| $7.15M | 1.11% | +42,600 | New | +$7.15M |
|